TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Australian Clinical Labs Ltd ( (AU:ACL) ) has provided an announcement.
Australian Clinical Labs Ltd announced an update on its ongoing share buy-back program, revealing that a total of 1,006,789 securities had been bought back before the previous day, with an additional 196,687 securities purchased on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:ACL) stock is a Hold with a A$3.00 price target. To see the full list of analyst forecasts on Australian Clinical Labs Ltd stock, see the AU:ACL Stock Forecast page.
More about Australian Clinical Labs Ltd
Australian Clinical Labs Ltd operates in the healthcare industry, providing pathology services. The company focuses on delivering diagnostic services to healthcare professionals and patients across Australia.
Average Trading Volume: 932,703
Technical Sentiment Signal: Sell
Current Market Cap: A$548.1M
Find detailed analytics on ACL stock on TipRanks’ Stock Analysis page.